Nomura Holdings Inc. Has $1.27 Million Position in The Clorox Company $CLX

Key Points

• Nomura Holdings Inc. increased its stake in The Clorox Company by 53.5%, purchasing an additional 3,004 shares, bringing its total holdings to 8,616 shares valued at approximately $1.27 million.
• Clorox posted better-than-expected quarterly earnings with an Earnings Per Share (EPS) of $2.87, exceeding analyst estimates, alongside revenue growth of 4.5% year-over-year.
• The company recently declared a quarterly dividend increase, raising the payout to $1.24 per share, resulting in a current yield of 4.0%.

Nomura Holdings Inc. raised its position in The Clorox Company (NYSE:CLX - Free Report) by 53.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,616 shares of the company's stock after acquiring an additional 3,004 shares during the period. Nomura Holdings Inc.'s holdings in Clorox were worth $1,269,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Baird Financial Group Inc. increased its holdings in shares of Clorox by 2.8% during the 1st quarter. Baird Financial Group Inc. now owns 24,608 shares of the company's stock worth $3,624,000 after acquiring an additional 678 shares during the last quarter. Vident Advisory LLC increased its holdings in Clorox by 28.9% during the first quarter. Vident Advisory LLC now owns 3,623 shares of the company's stock worth $533,000 after buying an additional 813 shares during the last quarter. Magnetar Financial LLC purchased a new stake in shares of Clorox during the first quarter worth $7,899,000. WPG Advisers LLC purchased a new position in Clorox in the first quarter worth $68,000. Finally, State of Wyoming purchased a new stake in shares of Clorox during the first quarter worth about $357,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Price Performance

NYSE CLX traded down $1.33 during midday trading on Monday, hitting $125.71. The company had a trading volume of 1,171,793 shares, compared to its average volume of 1,669,468. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a 50-day moving average price of $124.17 and a 200-day moving average price of $133.21. The company has a market capitalization of $15.37 billion, a PE ratio of 19.29, a P/E/G ratio of 1.02 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the firm earned $1.82 EPS. The firm's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a dividend of $1.24 per share. The ex-dividend date was Wednesday, August 13th. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a yield of 3.9%. Clorox's dividend payout ratio (DPR) is 76.07%.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research reports. Jefferies Financial Group reduced their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Citigroup reiterated a "neutral" rating and set a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Barclays reduced their target price on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Morgan Stanley dropped their price objective on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a report on Monday. One analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of "Reduce" and an average target price of $142.18.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.